Extended-Release Amantadine for Levodopa-Induced Dyskinesia.

Extended-Release Amantadine for Levodopa-Induced Dyskinesia.
Related ArticlesExtended-Release Amantadine for Levodopa-Induced Dyskinesia. Expert Rev Neurother. 2019 Mar 20;:1-7 Authors: Dashtipour K, Tafreshi AR, Pahwa R, Lyons KE Abstract INTRODUCTION: Levodopa-induced dyskinesia (LID) is a significant impediment to the long-term use of levodopa for Parkinson's disease (PD). Relatively few studies exist that have described safe and effective therapy for LID. There is thus a significant need for ... read more
Source: PubMedPublished on 2019-03-21